| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 160 E TASMAN DR | SAN JOSE | CA | 95134-1619 | SANTA CLARA | USA | R44GM144009 | A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | 000 | 3 | NIH | 4/11/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $801,485 ) |
| | 2024 | 2024 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R44GM145015 | Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization | 000 | 2 | NIH | 7/25/2024 | $801,485 |
| | 2024 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 160 E TASMAN DR | SAN JOSE | CA | 95134-1619 | SANTA CLARA | USA | R43HG012528 | Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development | 000 | 1 | NIH | 7/1/2024 | $0 |
| | 2024 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 160 E TASMAN DR | SAN JOSE | CA | 95134-1619 | SANTA CLARA | USA | R43AG080878 | EXODOTS for diagnostic evaluation and monitoring of Alzheimer's disease | 000 | 1 | NIH | 7/1/2024 | $0 |
| | 2024 | 2021 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 160 E TASMAN DR | SAN JOSE | CA | 95134-1619 | SANTA CLARA | USA | R41AG076098 | EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | 000 | 1 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $749,163 ) |
| | 2023 | 2023 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R44GM144009 | A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | 000 | 3 | NIH | 6/13/2023 | $749,163 |
| | 2023 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43GM145015 | Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization | 000 | 1 | NIH | 9/28/2023 | $0 |
| | 2023 | 2021 | WELLSIM BIOMEDICAL TECHNOLOGIES INC | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43GM144009 | A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | 000 | 1 | NIH | 11/17/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,655,029 ) |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R41AG076098 | EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | 000 | 1 | NIH | 8/29/2022 | $110,405 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43GM145015 | Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization | 000 | 1 | NIH | 2/10/2022 | $249,974 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43GM145015 | Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization | 001 | 1 | NIH | 3/28/2022 | $6,500 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R44GM144009 | A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | 000 | 2 | NIH | 6/16/2022 | $749,646 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R41AG076098 | EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | 002 | 1 | NIH | 9/16/2022 | $0 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43HG012528 | Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development | 000 | 1 | NIH | 8/12/2022 | $246,812 |
| | 2022 | 2022 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43AG080878 | EXODOTS for diagnostic evaluation and monitoring of Alzheimer's disease | 000 | 1 | NIH | 9/21/2022 | $291,692 |
| | 2022 | 2021 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R41AG076098 | EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | 001 | 1 | NIH | 9/15/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $448,859 ) |
| | 2021 | 2021 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R43GM144009 | A Label-free Extracellular-vesicle Automated Purification System (LEAP System) | 000 | 1 | NIH | 8/18/2021 | $197,500 |
| | 2021 | 2021 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | 930 CORAL RIDGE CIR | RODEO | CA | 94572-1808 | CONTRA COSTA | USA | R41AG076098 | EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease | 000 | 1 | NIH | 9/21/2021 | $251,359 |
|
|
